About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

Not Yet RecruitingNANCT07612397

Effects of Jaw Clenching on Gait and Mobility in Stroke

The aim of this study is to investigate the immediate effects of jaw clenching on gait and functional mobility in patients with chronic stroke.

Lead sponsor: Bitlis Eren University•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Merve Tunçdemir, Asst. Prof.

CONTACT

5069452008 merve.kd@hotmail.com

Ömer Dursun, Assoc. Prof.

CONTACT

5426088687 fztomrdrsn@gmail.com

Sponsors

Lead Sponsor

Bitlis Eren University

This randomized sham-controlled crossover study aims to investigate the immediate effects of jaw clenching on gait and functional mobility in patients with chronic stroke. A minimum of 30 eligible patients will be included. Each participant will complete both the intervention and sham conditions in a randomized sequence.

Age

18 - 75 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Stroke occurred at least 6 months prior to enrollment.
•No cognitive or communication impairments that would interfere with participation.
•Ability to stand independently for 20 seconds or more.
•Ability to walk 10 meters independently, with or without walking aids or orthoses as needed.
•Age between 18 and 75 years.
•Lower extremity Brunnstrom stage of 4 or higher.

Exclusion Criteria

•Presence of severe osteoarthritis in the lower extremities.
•Diagnosis of cancer or diabetic neuropathy.
•Presence of vestibular disorders.
•Lower extremity ulceration or amputation.
•History of vertigo.
•Alcohol consumption within the past 24 hours.
•Hemodynamic instability.
•Stroke affecting the basilar artery or cerebellum (posterior circulation stroke).
•Presence of neurological disorders such as multiple sclerosis or Parkinson's disease.
•Acute lower extremity injury within the past 6 weeks.
•History of lower extremity surgery.

Related studies

Telerehabilitation In The Home After Stroke

NCT06682429 · Stroke

Brain-controlled Spinal Cord Stimulation in Participants With Chronic Stroke for Lower and Upper Limb Rehabilitation

NCT07610850 · Stroke, Hemiplegia

Catheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients With Atrial Fibrillation

NCT07441382 · Atrial Fibrillation (AF), Stroke, and more

kTMP-Enhanced Motor Rehabilitation for Chronic Stroke Recovery (KULMINATE) Pilot

NCT07631078 · Stroke, Chronic Stroke Patients, and more

Walking and Thinking - Brain Activity During Complex Walking in Stroke

NCT07624630 · Stroke, Aging, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 28, 2026Terms

Trial snapshot

StatusNOT_YET_RECRUITING

PhaseNA

Enrollment30

Start dateJun 2026

Last updatedMay 28, 2026

Condition

Locations shown

Bolu İzzet Baysal Fizik Tedavi ve Rehabilitasyon Eğitim ve Araştırma Hastanesi

Bolu, Merkez

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 28, 2026Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions